Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

Vicky Chalos - Andreou; Rob van de Graaf; MR CLEAN-MED investigators; Bob Roozenbeek; Adriaan Es; H den Hertog; J Staals; L van Dijk; SFM Jenniskens; RJ van Oostenbrugge; WH Zwam; YBWEM Roos; C B M Majoie; Hester Lingsma; Aad van der Lugt; Diederik Dippel

doi:10.1186/s13063-020-04514-9

Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

Vicky Chalos - Andreou, Rob van de Graaf, MR CLEAN-MED investigators, Bob Roozenbeek, Adriaan Es, H den Hertog, J Staals, L van Dijk, SFM Jenniskens, RJ van Oostenbrugge, WH Zwam, YBWEM Roos, C B M Majoie, Hester Lingsma, Aad van der Lugt, Diederik Dippel

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

38 Downloads (Pure)

Original language	English
Article number	644
Journal	Trials
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13063-020-04514-9
Publication status	Published - 2020

Research programs

EMC COEUR-09
EMC NIHES-02-65-01
EMC NIHES-03-30-02

Access to Document

10.1186/s13063-020-04514-9

Repub_128994_O-A.pdfFinal published version, 1.15 MB

http://hdl.handle.net/1765/128994

Cite this

Chalos - Andreou, V., van de Graaf, R., MR CLEAN-MED investigators, Roozenbeek, B., Es, A., den Hertog, H., Staals, J., van Dijk, L., Jenniskens, SFM., van Oostenbrugge, RJ., Zwam, WH., Roos, YBWEM., Majoie, C. B. M., Lingsma, H., van der Lugt, A., & Dippel, D. (2020). Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design. Trials, 21(1), Article 644. https://doi.org/10.1186/s13063-020-04514-9

@article{ab8c3a0309554db38fd287cff4737612,

title = "Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design",

author = "{Chalos - Andreou}, Vicky and {van de Graaf}, Rob and {MR CLEAN-MED investigators} and Bob Roozenbeek and Adriaan Es and {den Hertog}, H and J Staals and {van Dijk}, L and SFM Jenniskens and {van Oostenbrugge}, RJ and WH Zwam and YBWEM Roos and Majoie, {C B M} and Hester Lingsma and {van der Lugt}, Aad and Diederik Dippel and Susan Olthuis",

year = "2020",

doi = "10.1186/s13063-020-04514-9",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

number = "1",

}

Chalos - Andreou, V , van de Graaf, R, MR CLEAN-MED investigators, Roozenbeek, B, Es, A, den Hertog, H, Staals, J, van Dijk, L, Jenniskens, SFM, van Oostenbrugge, RJ, Zwam, WH, Roos, YBWEM, Majoie, CBM, Lingsma, H , van der Lugt, A & Dippel, D 2020, 'Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design', Trials, vol. 21, no. 1, 644. https://doi.org/10.1186/s13063-020-04514-9

Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design. / Chalos - Andreou, Vicky ; van de Graaf, Rob; MR CLEAN-MED investigators et al.
In: Trials, Vol. 21, No. 1, 644, 2020.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

AU - Chalos - Andreou, Vicky

AU - van de Graaf, Rob

AU - MR CLEAN-MED investigators

AU - Roozenbeek, Bob

AU - Es, Adriaan

AU - den Hertog, H

AU - Staals, J

AU - van Dijk, L

AU - Jenniskens, SFM

AU - van Oostenbrugge, RJ

AU - Zwam, WH

AU - Roos, YBWEM

AU - Majoie, C B M

AU - Lingsma, Hester

AU - van der Lugt, Aad

AU - Dippel, Diederik

AU - Olthuis, Susan

PY - 2020

Y1 - 2020

U2 - 10.1186/s13063-020-04514-9

DO - 10.1186/s13063-020-04514-9

M3 - Article

C2 - 32665035

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

IS - 1

M1 - 644

ER -

Chalos - Andreou V , van de Graaf R, MR CLEAN-MED investigators, Roozenbeek B, Es A, den Hertog H et al. Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: Acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design. Trials. 2020;21(1):644. doi: 10.1186/s13063-020-04514-9